PHAXIAM Therapeutics S.A. (ERYFF)
PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
Address
60 AVENUE ROCKEFELLER
LYON, I0 69008
Founded
2004
Number of Employees
49
Website
http://www.phaxiam.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)